Cargando…

Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease

INTRODUCTION: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are important events that may precipitate other adverse outcomes. Accurate AECOPD event identification in electronic administrative data is essential for improving population health surveillance and practice manageme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mapel, Douglas W, Roberts, Melissa H, Sama, Susan, Bobbili, Priyanka J, Cheng, Wendy Y, Duh, Mei Sheng, Nguyen, Catherine, Thompson-Leduc, Philippe, Van Dyke, Melissa K, Rothnie, Kieran J, Sundaresan, Devi, Certa, Julia M, Whiting, Thomas S, Brown, Jennifer L, Roblin, Douglas W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200149/ https://www.ncbi.nlm.nih.gov/pubmed/34135580 http://dx.doi.org/10.2147/COPD.S302241

Ejemplares similares

A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
por: Mapel, Douglas, et al.
Publicado: (2017)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

Management of Asthma and Chronic Obstructive Pulmonary Disease with Combination Inhaled Corticosteroids and Long-Acting β-Agonists: A Review of Comparative Effectiveness Research
por: Mapel, Douglas W., et al.
Publicado: (2014)

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
por: Roberts, Melissa H, et al.
Publicado: (2015)

Clinical factors, including All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation
por: Roberts, Melissa H, et al.
Publicado: (2015)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
por: Roberts, Melissa H., et al.
Publicado: (2019)

Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods
por: Roberts, Melissa H., et al.
Publicado: (2015)

Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records
por: Whittaker, Hannah, et al.
Publicado: (2023)

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
por: Dalal, Anand A, et al.
Publicado: (2011)

The Epidemiology, Diagnosis, and Cost of Dyspepsia and Helicobater pylori Gastritis: A Case–Control Analysis in the Southwestern United States
por: Mapel, Douglas, et al.
Publicado: (2013)

Frailty Among Older Individuals with and without COPD: A Cohort Study of Prevalence and Association with Adverse Outcomes
por: Roberts, Melissa H, et al.
Publicado: (2022)

An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data
por: Mapel, Douglas W., et al.
Publicado: (2006)

Economic burden of chronic bronchitis in the United States: a retrospective case-control study
por: Blanchette, Christopher M, et al.
Publicado: (2011)

Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes
por: Rothnie, Kieran J., et al.
Publicado: (2016)

A retrospective analysis to identify predictors of COPD-related rehospitalization
por: Roberts, Melissa H., et al.
Publicado: (2016)

Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD
por: Mapel, Douglas W, et al.
Publicado: (2013)

Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol
por: Morgan, Ann D, et al.
Publicado: (2016)

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
por: Requena, Gema, et al.
Publicado: (2023)

Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records
por: Rothnie, Kieran J., et al.
Publicado: (2016)

Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review
por: Czira, Alexandrosz, et al.
Publicado: (2023)

Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
por: Rothnie, Kieran J, et al.
Publicado: (2015)

The epidemiology and treatment of anal fissures in a population-based cohort
por: Mapel, Douglas W, et al.
Publicado: (2014)

Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study
por: Choi, Gwang-Seong, et al.
Publicado: (2022)

Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK
por: Rothnie, Kieran J, et al.
Publicado: (2023)

Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England
por: Sansbury, Leah B, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease is associated with an increased risk of herpes zoster: A retrospective United States claims database analysis
por: Thompson‐Leduc, Philippe, et al.
Publicado: (2022)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction
por: Yawn, Barbara P, et al.
Publicado: (2010)

Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2015)

Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England
por: Gokhale, Mugdha, et al.
Publicado: (2020)

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study
por: Bobbili, Priyanka, et al.
Publicado: (2020)

Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
por: McDonnell, Melissa J., et al.
Publicado: (2021)

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
por: Li, Qingling, et al.
Publicado: (2021)

24. Economic Burden of Herpes Zoster Among Individuals with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
por: Ghaswalla, Parinaz, et al.
Publicado: (2020)

Immediate and early discharge for patients with exacerbations of chronic obstructive pulmonary disease: is there a role in “real life”?
por: Chetty, Mahendran, et al.
Publicado: (2006)

Pollen Exposure and Associated Healthcare Utilization: A Population-based Study Using Health Maintenance Organization Data in the Washington, DC, Area
por: Roblin, Douglas W., et al.
Publicado: (2021)

Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer
por: Bobbili, Priyanka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rja54c1hfttupepheb01ldb5d